UBS Group’s Evoke Pharma EVOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,258
Closed -$5.56K 8971
2024
Q4
$5.56K Buy
1,258
+1,168
+1,298% +$5.16K ﹤0.01% 7399
2024
Q3
$428 Sell
90
-2
-2% -$10 ﹤0.01% 7727
2024
Q2
$586 Hold
92
﹤0.01% 7688
2024
Q1
$675 Sell
92
-151
-62% -$1.11K ﹤0.01% 7245
2023
Q4
$3.06K Buy
243
+17
+8% +$214 ﹤0.01% 6801
2023
Q3
$3.74K Buy
226
+134
+146% +$2.22K ﹤0.01% 6376
2023
Q2
$1.83K Hold
92
﹤0.01% 6766
2023
Q1
$2.1K Hold
92
﹤0.01% 7480
2022
Q4
$2.97K Hold
92
﹤0.01% 8396
2022
Q3
$2K Sell
92
-385
-81% -$8.37K ﹤0.01% 8609
2022
Q2
$19K Buy
477
+305
+177% +$12.1K ﹤0.01% 5901
2022
Q1
$12K Buy
172
+147
+588% +$10.3K ﹤0.01% 7118
2021
Q4
$2K Buy
25
+9
+56% +$720 ﹤0.01% 8663
2021
Q3
$3K Sell
16
-104
-87% -$19.5K ﹤0.01% 7652
2021
Q2
$24K Sell
120
-101
-46% -$20.2K ﹤0.01% 6046
2021
Q1
$58K Buy
221
+209
+1,742% +$54.9K ﹤0.01% 5395
2020
Q4
$5K Sell
12
-58
-83% -$24.2K ﹤0.01% 6796
2020
Q3
$47K Buy
70
+66
+1,650% +$44.3K ﹤0.01% 4844
2020
Q2
$2K Buy
4
+2
+100% +$1K ﹤0.01% 6764
2020
Q1
$0 Sell
2
-20
-91% ﹤0.01% 7054
2019
Q4
$5K Buy
+22
New +$5K ﹤0.01% 6495
2019
Q2
Sell
-14
Closed -$3K 7010
2019
Q1
$3K Sell
14
-8
-36% -$1.71K ﹤0.01% 6496
2018
Q4
$8K Sell
22
-26
-54% -$9.46K ﹤0.01% 6412
2018
Q3
$21K Buy
48
+45
+1,500% +$19.7K ﹤0.01% 5853
2018
Q2
$1K Sell
3
-17
-85% -$5.67K ﹤0.01% 6884
2018
Q1
$6K Sell
20
-3
-13% -$900 ﹤0.01% 6248
2017
Q4
$7K Buy
23
+7
+44% +$2.13K ﹤0.01% 6248
2017
Q3
$7K Hold
16
﹤0.01% 6143
2017
Q2
$6K Hold
16
﹤0.01% 6096
2017
Q1
$7K Buy
+16
New +$7K ﹤0.01% 5884
2016
Q4
Sell
-2
Closed -$1K 6782
2016
Q3
$1K Sell
2
-15
-88% -$7.5K ﹤0.01% 6562
2016
Q2
$16K Buy
+17
New +$16K ﹤0.01% 5576
2016
Q1
Sell
-9
Closed -$4K 6740
2015
Q4
$4K Buy
+9
New +$4K ﹤0.01% 6385
2015
Q1
Sell
-3
Closed -$2K 6700
2014
Q4
$2K Buy
+3
New +$2K ﹤0.01% 6592